| Description |
Following the repeated success of our Adaptive Clinical Trials events in past years, VIBpharma is proud to announce Adaptive Clinical Trials 2009.
In a challenging economic climate in which the efficient use of resources has become increasingly important, adaptive trials represent significant potential savings in terms of time and money.
However, developing an adaptive design that delivers genuine savings is not necessarily straightforward. Negotiating the increased complexity and taking advantage of the potential time savings requires careful planning and a comprehensive understanding of the design and logistical challenges.
VIBpharma’s Adaptive Clinical Trials will enable you to access new case studies and learn from the experiences of the increasing number of major pharma companies who have embarked on adaptive trials. The event is split into two streams in order to provide in-depth, targeted information for both a clinical and a statistical audience and is relevant across all therapeutic disciplines. The event will cover topics such as trial design, the practical implications of making an adaptation on the supply chain, along with data collection and analysis. There will also be extensive coverage and opportunities for debate on the latest industry guidelines.
If you are looking into using adaptive trials, would like to expand your knowledge, or are experienced in adaptive trials and would benefit from discussing key industry and regulatory developments with your peers, this a must attend event.
The event will consist of:
An update from the regulators on the latest guidelines and an appraisal of what they look for in adaptive design
A broad range of case studies from across all phases and therapeutic areas to give you an in depth knowledge of what is working and what isn’t
Carefully researched round table discussions designed to focus on the key questions you have about adaptive trials, their design and execution
An examination of the business case for adaptive trials. Do they save time and money?
|
|
